Evaluation Of Cost-Effectiveness Of Glycopyrronium Vs. Tiotropium In The Management Of Chronic Obstructive Pulmonary Disease In Taiwan

被引：0
|
作者：
Chan, M. -C. [1 ]
Lin, T. -C. [2 ]
Yang, Y. Kao [2 ]
机构：
[1] Taichung Vet Gen Hosp, Taichung, Taiwan
[2] Natl Cheng Kung Univ, Tainan, Taiwan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1403
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden
    Madlaina Costa-Scharplatz
    Björn Ställberg
    Pankaj Goyal
    Yumi Asukai
    Jean-Bernard Gruenberger
    David Price
    [J]. Applied Health Economics and Health Policy, 2015, 13 : 637 - 645
  • [2] Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden
    Costa-Scharplatz, Madlaina
    Stallberg, Bjorn
    Goyal, Pankaj
    Asukai, Yumi
    Gruenberger, Jean-Bernard
    Price, David
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2015, 13 (06) : 637 - 645
  • [3] Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
    Dhvani Shah
    Maurice Driessen
    Nancy Risebrough
    Timothy Baker
    Ian Naya
    Andrew Briggs
    Afisi S. Ismaila
    [J]. Cost Effectiveness and Resource Allocation, 16
  • [4] Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
    Oskar Eklund
    Faraz Afzal
    Fredrik Borgström
    [J]. Cost Effectiveness and Resource Allocation, 13
  • [5] Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
    Eklund, Oskar
    Afzal, Faraz
    Borgstrom, Fredrik
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2015, 13
  • [6] Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective
    Shah, Dhvani
    Driessen, Maurice
    Risebrough, Nancy
    Baker, Timothy
    Naya, Ian
    Briggs, Andrew
    Ismaila, Afisi S.
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2018, 16
  • [7] COST-EFFECTIVENESS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN BRAZIL
    Tozato, C.
    Suzuki, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S411 - S411
  • [8] Evaluating the cost-effectiveness of tiotropium in the treatment of moderate chronic obstructive pulmonary disease
    Naik, S.
    Kamal, K. M.
    Keys, P.
    Mattei, T.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A178 - A179
  • [9] Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
    Eklund, Oskar
    Afzal, Faraz
    Borgstrom, Fredrik
    Flavin, Jason
    Ternouth, Andrew
    Ojanguren, Maria Eugenia
    Crespo, Carlos
    Baldwin, Mike
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 243 - 252
  • [10] COST-EFFECTIVENESS ANALYSIS OF GLYCOPYRRONIUM BROMIDE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN
    Torres, C.
    Betoret, I
    Sabater, E.
    Figueras, M.
    Casado, M. A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A372 - A372
12345